Kovachich G B, Aronson C E, Brunswick D J, Frazer A
Neuropsychopharmacology Unit, Veterans Administration Medical Center, Philadelphia, PA 19104.
Brain Res. 1988 Jun 28;454(1-2):78-88. doi: 10.1016/0006-8993(88)90805-0.
The binding of [3H]cyanoimipramine to serotonin uptake sites in rat brain slices was studied using quantitative autoradiography. Binding was of high affinity and was to a single class of binding site. This is in contrast to results previously obtained by others with [3H]imipramine where two binding sites were observed. The sites labeled by [3H]cyanoimipramine had properties consistent with this ligand labeling serotonin uptake sites, as: (1) binding is displaced by drugs which are potent inhibitors of serotonin uptake but not by drugs which are weak inhibitors of uptake; (2) binding is dependent on the presence of sodium ions as is the uptake of serotonin; (3) binding is almost completely eliminated in the brains of rats lesioned by the serotonin neurotoxin 5,7-dihydroxytryptamine; (4) the distribution of binding sites throughout the rat brain is highly correlated with that found previously for [3H]indalpine, a potent serotonin uptake inhibitor, and for [3H]imipramine. The properties of binding of [3H]cyanoimipramine make it an ideal ligand for the quantitative autoradiography of serotonin uptake sites.
利用定量放射自显影技术研究了[3H]氰米帕明与大鼠脑切片中5-羟色胺摄取位点的结合情况。结合具有高亲和力,且针对单一类别的结合位点。这与其他人先前用[3H]米帕明得到的结果形成对比,在后者的研究中观察到了两个结合位点。[3H]氰米帕明标记的位点具有与该配体标记5-羟色胺摄取位点相符的特性,具体如下:(1)结合可被强效5-羟色胺摄取抑制剂取代,但不能被弱摄取抑制剂取代;(2)结合依赖于钠离子的存在,5-羟色胺的摄取同样如此;(3)在被5-羟色胺神经毒素5,7-二羟基色胺损伤的大鼠脑中,结合几乎完全消失;(4)整个大鼠脑中结合位点的分布与先前发现的强效5-羟色胺摄取抑制剂[3H]茚达品以及[3H]米帕明的分布高度相关。[3H]氰米帕明的结合特性使其成为5-羟色胺摄取位点定量放射自显影的理想配体。